HAE News and Press, Haemonetics Corporation From 02/24/25

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference PR Newswire BOSTON , Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will participate in a fireside chat w...

2025-02-20 06:54:03 ET Summary Haemonetics shares have been trading at more appealing levels after a reduction in full-year sales guidance, trading at historically reasonable levels. The company, generating $1.3 billion in annual sales, has seen modest growth, with significant con...

2025-02-07 09:03:14 ET More on Haemonetics Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript Haemonetics: Reassessing Its Growth Trajectory (Rating Downgrade) Haemonetics' stock slides on revenue miss Haemonetics targets 24% to 26% hospital reven...

2025-02-06 13:59:24 ET Haemonetics Corporation ( NYSE: HAE ) stock dropped about 12% after the blood supplies company missed Q3 revenue estimates, despite posting a 3.7% year-over-year increase.... Read the full article on Seeking Alpha For further details see: Haemo...

2025-02-06 12:20:09 ET More on Haemonetics Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript Haemonetics: Reassessing Its Growth Trajectory (Rating Downgrade) Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript Haemonetics reports mixe...

2025-02-06 12:19:40 ET Haemonetics Corporation (HAE) Q3 2025 Earnings Conference Call February 06, 2025, 08:30 AM ET Company Participants Olga Guyette - Vice President, Investor Relations and Treasury Christopher Simon - President and Chief Executive Officer Jame...

2025-02-06 06:26:05 ET More on Haemonetics Haemonetics: Reassessing Its Growth Trajectory (Rating Downgrade) Corporate candidates to announce accelerate share buybacks: Trivariate Seeking Alpha’s Quant Rating on Haemonetics Read the full article on S...

First National Corporation (FXNC) is expected to report $0.47 for Q4 2024 Insight Enterprises Inc. (NSIT) is expected to report $2.53 for Q4 2024 Phillips Edison & Company Inc. (PECO) is expected to report $0.61 for Q4 2024 Lumentum Holdings Inc. (LITE) is expected to report $-0.0...

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website PR Newswire Financial release accessible online BOSTON , Feb. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial r...

2025-02-05 12:07:17 ET More on Haemonetics Haemonetics: Reassessing Its Growth Trajectory (Rating Downgrade) Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript Corporate candidates to announce accelerate share buybacks: Trivariate Haemonetics star...